Bank Analysts Reiterate Stock Ratings on These Shares September 27th

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on September 27th:

  • Integrated Device (NASDAQ:IDTI): Canaccord Genuity reiterated its rating of Buy for this company and changed its price target from $8 to $7. About the company: Integrated Device Technology, Inc. designs, develops, manufactures, and markets a variety of semiconductor products and modules. Applications for the Company’s products include data and telecommunications equipment, storage area networks, networked peripherals and servers, and personal computers. The Company markets its products on a worldwide basis primarily to original equipment manufacturers.
  • Stryker (NYSE:SYK): Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $68 to $61. About the company: Stryker Corporation develops, manufactures, and markets specialty surgical and medical products. The Company’s products include implants, biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment.
  • Ralcorp Holdings (NYSE:RAH): Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $91 to $84. About the company: Ralcorp Holdings, Inc. produces a variety of store brand foods that are sold under the individual labels of various grocery, mass merchandise, and drug store retailers. The Company’s products include cereals, crackers and cookies, snack nuts, chocolate candy, salad dressings, mayonnaise, peanut butter, jams, syrups, and sauces. Ralcorp also holds a partial interest in Vail Resorts, Inc.
  • Alexion Pharma (NASDAQ:ALXN): Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $63 to $74. About the company: Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.
  • KEYW Holding (NASDAQ:KEYW): FBR Capital reiterated its rating of Outperform for this company and changed its price target from $18 to $15. About the company: The Keyw Holding Corp. provides mission-critical cybersecurity and cyber superiority solutions to defense, intelligence and national security agencies. The Company’s solutions, services and products support the collection, processing, analysis, and use of intelligence data and information in the domain of cyberspace.
  • Zalicus (NASDAQ:ZLCS): Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $4 to $3. About the company: Zalicus Inc is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. The Company’s drug pipeline includes an arthritis formula in phase 2 development.
  • Church & Dwight (NYSE:CHD): Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $44 to $50. About the company: Church & Dwight Co., Inc. produces sodium bicarbonate and sodium bicarbonate-based products. The Company sells its products, primarily under the ARM & HAMMER trademark, to consumers and to industrial customers and distributors. Church & Dwight provides products such as baking soda, carpet deodorizer, and laundry detergent, as well as Brillo soap pads.
  • Tronox (TROX): Ticonderoga reiterated its rating of Buy for this company and changed its price target from $200 to $166.
  • Yahoo! (NASDAQ:YHOO): The Benchmark Company reiterated its rating of Hold for this company and changed its price target from $15 to $17. About the company: Yahoo! Inc. is a global Internet media company that offers an online guide to Web navigation, aggregated information content, communication services, and commerce. The Company’s site includes a hierarchical, subject-based directory of Web sites, which enables users to locate and access information and services through hypertext links included in the directory.
  • First Niagara (NASDAQ:FNFG): FBR Capital reiterated its rating of Outperform for this company and changed its price target from $16 to $12. About the company: First Niagara Financial Group, Inc. is a bank holding company. The Banks provide an array of deposit products and loans, as well as insurance, leasing, investment advisory services, insurance agency services, and trust services.
  • Regency Centers (NYSE:REG): Robert W. Baird reiterated its rating of Neutral for this company and changed its price target from $46 to $42. About the company: Regency Centers Corporation is a self-administered and self-managed real estate investment trust that owns and operates grocery anchored neighborhood retail centers. The Company currently owns and operates properties in various states located throughout the United States.
  • Federal Realty Invst Trust (NYSE:FRT): Robert W. Baird reiterated its rating of Outperform for this company and changed its price target from $92 to $90. About the company: Federal Realty Investment Trust is a self-administered real estate investment trust. The Company specializes in the ownership, management, development, and redevelopment of prime community and neighborhood shopping centers.

(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>